Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Diabetes Drug's role in ICU survival under scrutiny

NCT ID NCT07300293

First seen Jan 03, 2026 · Last updated Apr 30, 2026 · Updated 15 times

Summary

This study examines whether taking metformin before being admitted to the intensive care unit (ICU) affects survival in patients with type 2 diabetes who develop severe lactic acidosis. Researchers will review records of 100 adults admitted to a French hospital over a 10-year period. The goal is to clarify the controversial link between metformin and outcomes in this critical setting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Service de Médecine Intensive - Réanimation - CHU de Strasbourg - France

    RECRUITING

    Strasbourg, 67091, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.